You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inotuzumab Ozogamicin

Showing 76 - 100 of 117
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Withdrawn
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +7 more
  • gemtuzumab ozogamicin
  • laboratory biomarker analysis
  • (no location specified)
Jun 29, 2018

Lymphoma, B-Cell Trial (Inotuzumab Ozogamicin (CMC-544))

Completed
  • Lymphoma, B-Cell
  • Inotuzumab Ozogamicin (CMC-544)
  • (no location specified)
Dec 7, 2015

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Approved for marketing
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +9 more
  • gemtuzumab ozogamicin
  • laboratory biomarker analysis
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Feb 28, 2018

Acute Myeloid Leukemia Trial in France (Gemtuzumab ozogamicin (GO))

Unknown status
  • Acute Myeloid Leukemia
  • Gemtuzumab ozogamicin (GO)
  • Amiens, France
  • +20 more
Jul 24, 2018

DLBCL Trial in Belgium, France (Rituximab, CMC544, Gemcitabine and Oxaliplatine)

Completed
  • Diffuse Large B-Cell Lymphoma
  • Rituximab, CMC544, Gemcitabine and Oxaliplatine
  • Bruges, Belgium
  • +10 more
May 20, 2016

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +14 more
  • gemtuzumab ozogamicin
  • +2 more
  • Stanford, California
  • +3 more
May 30, 2017

Relapsed/Refractory Acute Myeloid Leukemia Included inPatient

Unknown status
  • Leukemia, Myeloid, Acute
  • Gemtuzumab Ozogamicin (GO)
  • Amiens, France
  • +10 more
Jan 23, 2018

Leukemia, MDS Trial in United Kingdom (cytarabine, daunorubicin HCl, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • Basingstoke, England, United Kingdom
  • +5 more
Sep 19, 2016

Leukemia Trial in Puerto Rico, United States (ara-C, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • Anniston, Alabama
  • +77 more
Jul 12, 2016

DNA Samples From Younger Newly Diagnosed Acute Myeloid Leukemia

Completed
  • Leukemia
  • DNA analysis
  • +3 more
  • (no location specified)
May 17, 2016

DNA Samples From Acute Myeloid Leukemia Treated on COG-AAML0531

Completed
  • Leukemia
  • DNA analysis
  • +3 more
  • (no location specified)
May 17, 2016

Acute Myeloid Leukemia Trial in Aarhus, Copenhagen (Gemtuzumab ozogamicin)

Completed
  • Acute Myeloid Leukemia
  • Gemtuzumab ozogamicin
  • Aarhus, Denmark
  • +1 more
May 12, 2016

Acute Myeloid Leukemia Trial in Pittsburgh (Gemtuzumab ozogamicin, Mitoxantrone, Etoposide)

Terminated
  • Acute Myeloid Leukemia
  • Gemtuzumab ozogamicin
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute / Hillman Cancer Cente
Jan 14, 2016

Leukemia Trial in Canada, Sweden, United States (gemtuzumab ozogamicin, observation, Cytosine arabinoside)

Completed
Has Results
  • Leukemia
  • gemtuzumab ozogamicin
  • +3 more
  • Anchorage, Alaska
  • +278 more
Sep 25, 2015

Leukemia, MDS Trial in Cleveland (arsenic trioxide, gemtuzumab ozogamicin)

Completed
Has Results
  • Leukemia
  • Myelodysplastic Syndromes
  • arsenic trioxide
  • gemtuzumab ozogamicin
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Center
Jul 6, 2015

Leukemia Trial in United States (cytarabine, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • Berkeley, California
  • +150 more
Mar 5, 2015

Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in New York City (Gemtuzumab

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • Gemtuzumab Ozogamicin
  • +6 more
  • New York City, New York
    Morgan Stanley Children's Hospital of NYP
Apr 20, 2015

S9031-9333-0106-0112-A Study of Biomarkers in Samples From Acute

Completed
  • Leukemia
  • DNA analysis
  • +5 more
  • (no location specified)
Mar 5, 2015

Acute Myeloid Leukemia Trial in Udine (FLAIMy - Fluda, Ida, Ara-C, Mylotarg)

Completed
  • Acute Myeloid Leukemia
  • FLAIMy - Fluda, Ida, Ara-C, Mylotarg
  • Udine, Italy
    University Hospital, Udine
May 5, 2014

Leukemia, MDS Trial in Australia, Canada, United States (asparaginase, cytarabine, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • Birmingham, Alabama
  • +75 more
Feb 18, 2014

Leukemia Trial in Berkeley Heights (oblimersen sodium, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • oblimersen sodium
  • gemtuzumab ozogamicin
  • Berkeley Heights, New Jersey
    Genta Incorporated
Jan 3, 2014

Leukemia Trial in Worldwide (asparaginase, busulfan, cyclophosphamide)

Completed
  • Leukemia
  • Birmingham, Alabama
  • +147 more
Feb 19, 2014

Leukemia, MDS Trial in United Kingdom (biological, drug, genetic, other, procedure)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • alemtuzumab
  • +18 more
  • Basingstoke, England, United Kingdom
  • +95 more
Aug 23, 2013

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Decitabine, Gemtuzumab ozogamicin)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 3, 2013

Acute Myeloblastic Leukemia Trial in Valencia (gemtuzumab)

Completed
  • Acute Myeloblastic Leukemia
  • Valencia, Spain
    Hoapital La Fe
Jul 30, 2013